Improved
6112 HealthChanged
3785 LivesSaved
3568 Lives0 lives impacted in the last 24 hrs Learn More
Dr. Singh explains how women can find a credible specialist to treat her ovarian cancer.
Dr. Singh:
So the hardest part of that ovarian cancer is it’s not if you’re diagnosed. If you’re diagnosed with ovarian cancer, do you need a gynecologic oncologist, yes, or you need a medical oncologist who treats a lot of ovarian cancer, right? The websites that can help you with that, the Gynecologic Cancer Foundation or Women’s Cancer Network, both have links to people who treat ovarian cancer.
It’s a very straightforward question to ask somebody who is taking care of you, "How much of this do you do?" Just the same way we talk to people about, and I have patients that ask me that all the time, “How many surgeries like these do you do?” Couple a week, you know, as opposed to a couple a year, right?
The same can be asked about chemotherapy. How much ovarian cancer do you take care of in your practice? The hard thing about it, though, and I think this is the message for women in general, is that it’s not after you’re diagnosed, it’s when someone thinks you have ovarian cancer that you should see a gynecologic oncologist so you get the right surgery, right? It’s at that surgery that we make the diagnosis of ovarian cancer, and that surgery needs to be done correctly.
About Dr. Diljeet K. Singh, M.D., Dr.P.H.:
Dr. Diljeet K. Singh, M.D., Dr.P.H., is a gynecologic oncologist and is Co-Director of the Northwestern Ovarian Cancer Early Detection and Prevention Program. She is part of the Division of Gynecologic Oncology at the Robert H. Lurie Comprehensive Cancer Center of the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.
Dr. Singh attended medical school at the Feinberg School of Medicine at Northwestern University. She completed her residency at Johns Hopkins Hospital in Baltimore, Maryland, and her fellowship at the University of Texas MD Anderson Cancer Center in Houston, Texas.
Dr. Singh specializes in gynecologic, cervical, ovarian, uterine, vaginal, and vulvar cancers.